Nicolas Sax

KOTAI Biotechnol Inc

关注

立即认领

关注

立即认领

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

时间

引用量

主题

期刊级别

合作者

合作机构

Supplementary Figure S4 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

Takao Morinaga,Takashi Inozume,Masahito Kawazu,Youki Ueda,Nicolas Sax,Kazuo Yamashita,Shusuke Kawashima,Joji Nagasaki,Toshihide Ueno,Jason Lin,Yuuki Ohara,Takeshi Kuwata,Hiroki Yukami,Akihito Kawazoe,Kohei Shitara,Akiko Honobe-Tabuchi,Takehiro Ohnuma,Tatsuyoshi Kawamura,Yoshiyasu Umeda,Yu Kawahara,Yasuhiro Nakamura,Yukiko Kiniwa,Ayako Morita,Eiki Ichihara,Katsuyuki Kiura,Tomohiro Enokida,Makoto Tahara,Yoshinori Hasegawa,Hiroyuki Mano,Yutaka Suzuki,Hiroyoshi Nishikawa,Yosuke Togashi

openalex（2023）

引用0浏览0引用

CD62L Expression Marks SARS-CoV-2 Memory B Cell Subset with Preference for Neutralizing Epitopes

Taishi Onodera,Nicolas Sax,Takashi Sato,Yu Adachi,Ryutaro Kotaki,Takeshi Inoue,Ryo Shinnakasu,Takayuki Nakagawa,Shuetsu Fukushi,Tommy Terooatea,Mai Yoshikawa,Keisuke Tonouchi,Takaki Nagakura,Saya Moriyama,Takayuki Matsumura,Masanori Isogawa,Kazutaka Terahara,Tomohiro Takano,Lin Sun,Ayae Nishiyama,Shinnya Omoto,Masaharu Shinkai,Tomohiro Kurosaki,Kazuo Yamashita,Yoshimasa Takahashi

SCIENCE ADVANCESno. 24 (2023)

引用2浏览0WOSSCIENCE引用

Supplementary Figure S2 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

Supplementary Table S6. from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

Supplementary Table S8 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

Supplementary Figure S3 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

Tumor-derived Semaphorin 4A Improves PD-1–blocking Antibody Efficacy by Enhancing CD8 + T Cell Cytotoxicity and Proliferation

Yujiro Naito,Shohei Koyama,Kentaro Masuhiro,Takashi Hirai,Takeshi Uenami,Takako Inoue,Akio Osa,Hirotomo Machiyama,Go Watanabe,Nicolas Sax, Jordan Villa,Yumi Kinugasa-Katayama,Satoshi Nojima,Moto Yaga,Yuki Hosono,Daisuke Okuzaki,Shingo Satoh,Takeshi Tsuda,Yoshimitsu Nakanish,Yasuhiko Suga, Takayosh Morita,Kiyohar Fukushima,Masayuk Nishide,Takayuki Shiroyama,Kotaro Miyake,Kota Iwahori,Haruhiko Hirata,Izumi Nagatomo,Yukihiro Yano,Motohiro Tamiya,Toru Kumagai,Norihiko Takemoto,Hidenori Inohara,Sho Yamasaki,Kazuo Yamashita,Taiki Aoshi,Esra A. Akbay,Naoki Hosen,Yasush Shintani,Hyota Takamatsu,Masahide Mori,Yoshito Takeda,Atsushi Kumanogoh

SCIENCE ADVANCESno. 20 (2023)

引用12浏览0WOSSCIENCE引用

Supplementary Table S1 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

Supplementary Table S4 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

Supplementary Figure S6 from Mixed Response to Cancer Immunotherapy is Driven by Intratumor Heterogeneity and Differential Interlesion Immune Infiltration

openalex（2023）

引用0浏览0引用

加载更多

作者统计

#Papers: 20

#Citation: 245

H-Index: 7

G-Index: 9

Sociability: 5

Diversity: 1

Activity: 11

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn